You're viewing a free preview.You're viewing a free preview — a sample of each dataset.
News Feed
Daily longevity science headlines — aging research, deals, trials, and policy — with AI summaries.
566 news items tracked
| Headline | Published |
|---|---|
| Cognition Therapeutics aligns with FDA on a pivotal Phase 3 trial of zervimesine (CT1812) in dementia with Lewy bodies | 10/22/26 |
| Immunis wins the grand prize in the National Academy of Medicine Healthy Longevity Global Competition | 10/21/26 |
| Penn State: a four-minute daily exercise routine improved strength and balance in adults over 65 in a 97-person randomized trial | 10/21/26 |
| NRG Therapeutics announces a PET biodistribution trial of its lead clinical asset NRG5051 for ALS and Parkinson's | 10/21/26 |
| Muna Therapeutics reports positive Phase 1 results for MNA-001, an oral TREM2 modulator for Alzheimer's disease | 10/21/26 |
| Insilico Medicine and Servier reach the first milestone in their AI-driven oncology collaboration, triggering an undisclosed payment | 10/20/26 |
| L-Nutra Health opens its fasting-mimicking-diet metabolic health programme to UK clinics and practices | 10/20/26 |
| Nestle launches Solgar Prime, a premium supplement range for muscle strength, vitality and mobility, as a healthy-longevity growth platform | 10/19/26 |
| Veradermics oral VDPHL01 shows early, consistent hair growth in positive Phase 3 Study '304 in male pattern hair loss | 10/19/26 |
| News-Medical explainer: gut microbiome and aging, and what it means for health and longevity | 10/19/26 |
Showing 10 of 566 news items
7-day free trial · already have an account?
Peek at other modules
Companies
The longevity science company universe by segment, stage, geography and capital raised.
Funding Tracker
Every disclosed longevity science round — size, stage and the investors behind it.
Clinical Trials
Longevity science and aging research trials by phase, sponsor, status and indication.
People & Movers
Who is joining, leaving and founding across longevity science and aging research.
Research
Peer-reviewed aging research distilled into investor-relevant takeaways.
Regulatory
FDA, EMA and policy developments that move aging research and the longevity market.